1Ott BR, Zamani A, Kleefield J, et al. The clinical spectrum of hemorrhagic infarction[J]. Stroke, 1986, 17(4): 630-637.
2Chalela JA, Katzan I, Liebeskind DS, et al. Safety of intra-arterial therombolysis in postoperative period [J]. Stroke, 2001, 32 (6): 1365-1369.
3Silva Y, Leira R, Tejada J, et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage [J]. Stroke, 2005, 36(1): 86-91.
4Lindley RI, Wardlaw JM, Sandercock PA, et al. Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction[J]. J Stroke Cerebrovasc Dis, 2004, 13(6): 235-246.
5Schulman S, Beyth RJ, Kearon C, et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [J]. Chest, 2008, 133(6 Suppl): 2578-2988.
6Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update [J]. J Neurol Neurosurg Psychiatry, 2008, 79(10): 1093-1099.
7Brett C, Scott EK, David T, et a1. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the stroke-acute ischemic NXY treatment (SAINT) I and SAINT II trials[J]. Stroke, 2009,40(9): 3067-3072.
8Kidwell CS, Saver JL, Cameado J, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis [J]. Stroke, 2002, 33(3): 717-724.
9Michael DH, Alastair MB. Thrombolysis for acute ischemic stroke: results of the Canadian alteplase for stroke effectiveness study Pl. CMAJ,2005, 172(10): 1307-1312.
10Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial [J]. Neurology, 2001, 57(9): 1603-1610.
8Touze E, Mas JL, Rother J, et al. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack : results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Stroke, 2006, 37: 2880-2885.
9Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, 3: CD000213.
10Sacco RL, Chong JY, Prabhakaran S. Experimental treatments for acute ischaemie stroke. Lancet, 2007, 369:331-341.
5Bayramoglu M, Karatas M, Leblebici B, et al. Hemorrhagic Transfor- mation Stroke Patients[ J]. Amjphys Med Rehabi1,2003,82 (1) :48- 52.
6Richard I, Lindley, Joanna M, et al. Frequency and Risk Factors for Spontaneous Hemorrhagic Transformation of Cerebral Infarction [ J ]. Journal of Stroke and Cerebrovascular Diseases,2004,13 ( 6 ) :235 - 246.
7Talke PO,Sharma D, Heyer EJ, et al. Society for neuroscience in anesthesiology and critical care expert consensus statement: anesthetic management of endovascular treatment for acute is- chemic stroke[J]. J Neurosurg Anesthesiol, 2014,26 ( 2 ) : 95 -- 108.
8Adams HP, Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke[J]. Stroke, 2007, 38:1655--1711.
9Miller DJ, Simpson JR, Silver 13. Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies[J]. Neurohospitalist, 2011 ( 1 ) : 138-- 147.
10Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, N1NDS, and EPITHET trials [J], Lancet, 2010, 375(9727): 1695-1703. DOI: 10.1016/S0140-6736 (10)60491-6.
